Cardiological Monitoring – A Cornerstone for Pediatric Inflammatory Multisystem Syndrome Temporally Associated with COVID-19 Outcome: A Case Report and a Review from the Literature

1European Centre for Disease Prevention and Control. Paediatric inflammatory multisystem syndrome and SARS-CoV-2 infection in children. ECDC:Stockholm. 2020;15 May. European Centre for Disease Prevention and Control Paediatric inflammatory multisystem syndrome and SARS-CoV-2 infection in children ECDC:Stockholm 202015 MaySearch in Google Scholar

2Balasubramanian S, Nagendran TM, Ramachandran B, Ramanan AV. Hyper-inflammatory Syndrome in a Child With COVID-19 Treated Successfully With Intravenous Immunoglobulin and Tocilizumab. Indian Pediatr. 2020;57(7):681–3. Balasubramanian S Nagendran TM Ramachandran B Ramanan AV Hyper-inflammatory Syndrome in a Child With COVID-19 Treated Successfully With Intravenous Immunoglobulin and Tocilizumab Indian Pediatr 2020577681 310.1007/s13312-020-1901-z738726132393681Search in Google Scholar

3Marginean C, Melit L, Sasaran M. Pediatric obesity–a potential risk factor for systemic inflammatory syndrome associated to COVID-19, a case report. Front Pediatr. 2021;9:493. Marginean C Melit L Sasaran M Pediatric obesity–a potential risk factor for systemic inflammatory syndrome associated to COVID-19, a case report Front Pediatr 2021949310.3389/fped.2021.681626819270234123977Search in Google Scholar

4Davies P, Evans C, Kanthimathinathan HK, Lillie J, Brierley J, Waters G, et al. Intensive care admissions of children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS) in the UK: a multicentre observational study. Lancet Child Adolesc Health. 2020;4(9):669–77. Davies P Evans C Kanthimathinathan HK Lillie J Brierley J Waters G et al Intensive care admissions of children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS) in the UK: a multicentre observational study Lancet Child Adolesc Health 202049669 7710.1016/S2352-4642(20)30215-7734735032653054Search in Google Scholar

5Paediatric multisystem inflammatory syndrome temporally associated with COVID-19 (PIMS) - guidance for clinicians [Internet]. RCPCH. [cited 2021 Mar 7]. Available from: https://www.rcpch.ac.uk/resources/paediatric-multisystem-inflammatory-syndrome-temporally-associated-covid-19-pims-guidance Paediatric multisystem inflammatory syndrome temporally associated with COVID-19 (PIMS) - guidance for clinicians [Internet] RCPCH. [cited 2021 Mar 7]. Available from https://www.rcpch.ac.uk/resources/paediatric-multisystem-inflammatory-syndrome-temporally-associated-covid-19-pims-guidanceSearch in Google Scholar

6HAN Archive - 00432 | Health Alert Network (HAN) [Internet]. 2020 [cited 2021 Mar 7]. Available from: https://emergency.cdc.gov/han/2020/han00432.asp HAN Archive - 00432 | Health Alert Network (HAN) [Internet]. 2020 [cited 2021 Mar 7] Available from https://emergency.cdc.gov/han/2020/han00432.aspSearch in Google Scholar

7Multisystem inflammatory syndrome in children and adolescents temporally related to COVID-19 [Internet]. [cited 2021 Mar 7]. Available from: https://www.who.int/news-room/commentaries/detail/multisystem-inflammatory-syndrome-in-children-and-adolescents-with-covid-19 Multisystem inflammatory syndrome in children and adolescents temporally related to COVID-19 [Internet] [cited 2021 Mar 7]. Available from https://www.who.int/news-room/commentaries/detail/multisystem-inflammatory-syndrome-in-children-and-adolescents-with-covid-19Search in Google Scholar

8Mărginean CO, Meliţ LE, Chinceşan M, Mureşan S, Georgescu AM, Suciu N, et al. Communication skills in pediatrics - the relationship between pediatrician and child. Medicine (Baltimore). 2017;96(43):e8399. Mărginean CO Meliţ LE Chinceşan M Mureşan S Georgescu AM Suciu N et al Communication skills in pediatrics - the relationship between pediatrician and child Medicine (Baltimore) 20179643e839910.1097/MD.0000000000008399567186929069036Search in Google Scholar

9Verdoni L, Mazza A, Gervasoni A, Martelli L, Ruggeri M, Ciuffreda M, et al. An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study. Lancet Lond Engl. 2020;395(10239):1771–8. Verdoni L Mazza A Gervasoni A Martelli L Ruggeri M Ciuffreda M et al An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study Lancet Lond Engl 2020395102391771 810.1016/S0140-6736(20)31103-X722017732410760Search in Google Scholar

10Belhadjer Z, Méot M, Bajolle F, Khraiche D, Legendre A, Abakka S, et al. Acute Heart Failure in Multisystem Inflammatory Syndrome in Children in the Context of Global SARS-CoV-2 Pandemic. Circulation. 2020;142(5):429–36. Belhadjer Z Méot M Bajolle F Khraiche D Legendre A Abakka S et al Acute Heart Failure in Multisystem Inflammatory Syndrome in Children in the Context of Global SARS-CoV-2 Pandemic Circulation 20201425429 3610.1161/CIRCULATIONAHA.120.04836032418446Search in Google Scholar

11Bhat CS, Gupta L, Balasubramanian S, Singh S, Ramanan AV. Hyperinflammatory Syndrome in Children Associated With COVID-19: Need for Awareness. Indian Pediatr. 2020;57(10):929–35. Bhat CS Gupta L Balasubramanian S Singh S Ramanan AV Hyperinflammatory Syndrome in Children Associated With COVID-19: Need for Awareness Indian Pediatr 20205710929 3510.1007/s13312-020-1997-1760548732683336Search in Google Scholar

12Tullie L, Ford K, Bisharat M, Watson T, Thakkar H, Mullassery D, et al. Gastrointestinal features in children with COVID-19: an observation of varied presentation in eight children. Lancet Child Adolesc Health. 2020;4(7):e19–20. Tullie L Ford K Bisharat M Watson T Thakkar H Mullassery D et al Gastrointestinal features in children with COVID-19: an observation of varied presentation in eight children Lancet Child Adolesc Health 202047e19 2010.1016/S2352-4642(20)30165-6723736132442420Search in Google Scholar

13Whittaker E, Bamford A, Kenny J, Kaforou M, Jones CE, Shah P, et al. Clinical Characteristics of 58 Children With a Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2. JAMA. 2020;324(3):259–69. Whittaker E Bamford A Kenny J Kaforou M Jones CE Shah P et al Clinical Characteristics of 58 Children With a Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2 JAMA 20203243259 6910.1001/jama.2020.10369728135632511692Search in Google Scholar

14Riphagen S, Gomez X, Gonzalez-Martinez C, Wilkinson N, Theocharis P. Hyperinflammatory shock in children during COVID-19 pandemic. Lancet Lond Engl. 2020;395(10237):1607– 8. Riphagen S Gomez X Gonzalez-Martinez C Wilkinson N Theocharis P Hyperinflammatory shock in children during COVID-19 pandemic Lancet Lond Engl 2020395102371607 810.1016/S0140-6736(20)31094-1720476532386565Search in Google Scholar

15Sperotto F, Friedman KG, Son MBF, VanderPluym CJ, Newburger JW, Dionne A. Cardiac manifestations in SARS-CoV-2-associated multisystem inflammatory syndrome in children: a comprehensive review and proposed clinical approach. Eur J Pediatr. 2021;180(2):307–22. Sperotto F Friedman KG Son MBF VanderPluym CJ Newburger JW Dionne A Cardiac manifestations in SARS-CoV-2-associated multisystem inflammatory syndrome in children: a comprehensive review and proposed clinical approach Eur J Pediatr 20211802307 2210.1007/s00431-020-03766-6742912532803422Search in Google Scholar

16Grimaud M, Starck J, Levy M, Marais C, Chareyre J, Khraiche D, et al. Acute myocarditis and multisystem inflammatory emerging disease following SARS-CoV-2 infection in critically ill children. Ann Intensive Care. 2020;10(1):69. Grimaud M Starck J Levy M Marais C Chareyre J Khraiche D et al Acute myocarditis and multisystem inflammatory emerging disease following SARS-CoV-2 infection in critically ill children Ann Intensive Care 20201016910.1186/s13613-020-00690-8726612832488505Search in Google Scholar

17Burns JC, Franco A. The immunomodulatory effects of intravenous immunoglobulin therapy in Kawasaki disease. Expert Rev Clin Immunol. 2015;11(7):819–25. Burns JC Franco A The immunomodulatory effects of intravenous immunoglobulin therapy in Kawasaki disease Expert Rev Clin Immunol 2015117819 2510.1586/1744666X.2015.1044980498526326099344Search in Google Scholar

18Lo MS, Newburger JW. Role of intravenous immunoglobulin in the treatment of Kawasaki disease. Int J Rheum Dis. 2018;21(1):64–9. Lo MS Newburger JW Role of intravenous immunoglobulin in the treatment of Kawasaki disease Int J Rheum Dis 201821164 910.1111/1756-185X.1322029205910Search in Google Scholar

19Mărginean CO, Meliț LE, Gozar L, Mărginean CD, Mărginean MO. Incomplete Refractory Kawasaki Disease in an Infant-A Case Report and a Review of the Literature. Front Pediatr. 2018;6:210. Mărginean CO Meliț LE Gozar L Mărginean CD Mărginean MO Incomplete Refractory Kawasaki Disease in an Infant-A Case Report and a Review of the Literature Front Pediatr 2018621010.3389/fped.2018.00210607405730101141Search in Google Scholar

20Mărginean CO, Meliţ LE, Mărginean MO. The peculiarities of Kawasaki disease at the extremes of age: Two case reports. Medicine (Baltimore). 2019;98(42):e17595. Mărginean CO Meliţ LE Mărginean MO The peculiarities of Kawasaki disease at the extremes of age: Two case reports Medicine (Baltimore) 20199842e1759510.1097/MD.0000000000017595682463531626134Search in Google Scholar

21Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ, et al. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet Lond Engl. 2020;395(10229):1033–4. Mehta P McAuley DF Brown M Sanchez E Tattersall RS Manson JJ et al COVID-19: consider cytokine storm syndromes and immunosuppression Lancet Lond Engl 2020395102291033 410.1016/S0140-6736(20)30628-0727004532192578Search in Google Scholar

22Pacha O, Sallman MA, Evans SE. COVID-19: a case for inhibiting IL-17? Nat Rev Immunol. 2020;20(6):345–6. Pacha O Sallman MA Evans SE COVID-19: a case for inhibiting IL-17? Nat Rev Immunol 2020206345 610.1038/s41577-020-0328-z719424432358580Search in Google Scholar